Author

Aashreya Ravichandra

Technical University of MunichORCID 0000-0001-5785-8524Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:scRNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1 Organism:human· 1 Research Focus:spatial domain detection· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Allan PavyiD· 1 shared Anna ChernyshevaiD· 1 shared Anna Melissa SchlitteriD· 1 shared Carlos Andres Roldan-HernandeziD· 1 shared Carolin MogleriD· 1 shared Cédric CoulouarniD· 1 shared Corentin LouisiD· 1 shared Daniele LucarelliiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Allan PavyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 27, 2026

Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model

Raphela A. Ranjan, Aashreya Ravichandra, Philipp Putze…·Maximilian Reichert

This study uses an in ovo model to show that the CAM platform supports tumor-stroma coevolution in pancreatic cancer, preserving patient-specific features and enabling functional analysis of stromal interactions.

DOI 10.64898/2026.06.26.734719

chicken / avianscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 10, 2025

ZEB1 regulates BCL2 in cancer-associated fibroblasts to promote cholangiocarcinoma chemoresistance to gemcitabine and cisplatin

Ester Gonzalez‐Sanchez, Marie Vallette, Aashreya Ravichandra…·Javier Vaquero

This study shows ZEB1 in cancer-associated fibroblasts regulates BCL2 to promote chemoresistance in cholangiocarcinoma, suggesting BCL2 inhibitors could enhance gemcitabine and cisplatin efficacy.

DOI 10.1101/2025.09.10.675294

humanscRNA-seq

𝕏 PostBluesky